drugset / Trial / NCT00025649

Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma

NCT00025649 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy given before surgery followed by peripheral stem cell or bone marrow transplantation in treating infants who have newly diagnosed neuroblastoma.

Timeline

Start
1999-07
Primary completion
—
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule — Intravenous
Subject Carboplatin Small molecule — Intravenous
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Doxorubicin Other / unclassified — Intravenous
Subject Etoposide Small molecule — Intravenous
Subject Melphalan Small molecule — Intravenous
Subject Vincristine Small molecule — Intravenous
Background filgrastim Protein / enzyme biologic — Subcutaneous

Indications